Target intelligence / Profile preview

RPS3A pseudogene 7 (RPS3AP7)

Target
RPS3AP7
Molecular classification
Other (Pseudogene)
01

Overview

RPS3A pseudogene 7 is a processed pseudogene of the ribosomal protein S3A gene. It is annotated as a pseudogene in public gene databases, meaning it does not encode a functional protein and is not involved in ribosomal assembly, translation, or other biological processes. There is no evidence that it serves as a therapeutic target, is implicated in disease, interacts with drugs, or functions as a biomarker[7][8][9].

Other names
RPS3A_5_169ribosomal protein S3a pseudogene 7

Beyond the preview

Go deeper on RPS3A pseudogene 7 (RPS3AP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPS3A pseudogene 7 (RPS3AP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call